Thomas Watkins Net Worth - Insider Trades and Bio as of Jun 13, 2026

Horizon Therapeutics Public Ltd CoSEC CIK: 0001307935

Estimated Net Worth

$13.9 Million

Last Updated: May 19, 2026 01:19 AM EST

Transaction Summary

Total Transactions66

Buy-Sell Ratio3.25

Buy Transactions13

Sell Transactions4

Transaction Volume

Total Volume$2.29M

Net Volume$2.88M

Buy Volume$2.58M

Sell Volume-$292.49K

Trade Analysis

AVG Trade Size-$1.02M

Largest Trade$1.45M

Most Active MonthJun

Most Active Year2014

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Thomas Watkins has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., Vanda Pharmaceuticals Inc., and HUMAN GENOME SCIENCES INC.

2014 was Thomas Watkins's most active year for acquiring shares with 8 total transactions. Thomas Watkins's most active month to acquire stocks was the month of May. 2023 was Thomas Watkins's most active year for disposing of shares, totalling 10 transactions. Thomas Watkins's most active month to dispose stocks was the month of June. 2023 saw Thomas Watkins paying a total of $1,106,550.01 for 89,252 shares, this is the most they've acquired in one year. In 2012 Thomas Watkins cashed out on 3,678,544.24 shares for a total of $50,039,505.42, their largest year based on trade value.

Holdings & Transactions

horizon therapeutics public ltd co

Updated: Oct 06, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	254.05K	$116.50	-$20.55M	Oct 06, 2023	—	Disposition	—	Oct 06	View
From 4	—	—	$13.61	$1.11M	Oct 02, 2023	187.24K	Options	—	Sep 29	View
From 4	—	4.02K	—	—	Jul 28, 2023	4.02K	Grant	—	Jul 27	View
From 4	—	—	—	—	May 02, 2023	95.08K	Options	—	Apr 28	View
From 4	0.05	3.91K	—	—	May 02, 2022	95.08K	Options	—	Apr 28 - 29	View
From 4	0.06	4.22K	—	—	Apr 30, 2021	91.16K	Options	—	Apr 29 - 30	View
From 4	0.19	11.10K	—	—	May 04, 2020	86.94K	Options	—	Apr 30 - 02	View
From 4	0.23	11.26K	$26.54	-$109.66K	May 06, 2019	75.84K	Options	—	May 02 - 03	View
From 4	1.43	47.48K	—	—	May 07, 2018	96.75K	Options	—	May 03	View
From 4	2.35	45.21K	—	—	May 04, 2017	80.42K	Options	—	May 03	View
From 4	—	—	—	—	May 10, 2016	21.26K	Options	—	May 06	View
From 4	—	37.05K	—	—	May 05, 2016	37.05K	Grant	—	May 03	View
From 4	—	10.00K	$31.32	$313.24K	Aug 21, 2015	16.00K	Purchase	—	Aug 19	View
From 4	—	13.81K	—	—	May 08, 2015	13.81K	Grant	—	May 06	View
From 4/A	—	6.00K	—	—	Jan 26, 2015	6.00K	Grant	—	Sep 19	View
From 4/A	-1.00	6.00K	—	—	Jan 26, 2015	—	Disposition	—	Sep 19	View
From 4	—	6.00K	$9.76	$58.56K	Jan 26, 2015	6.00K	Purchase	—	Aug 14	View
From 4	—	60.00K	—	—	Sep 22, 2014	60.00K	Grant	—	Sep 19	View
From 3	—	—	—	—	Sep 22, 2014	—	—	—	—	View
From 4	-1.00	60.00K	—	—	Sep 22, 2014	—	Disposition	—	Sep 19	View
From 4	—	20.00K	—	—	Jun 30, 2014	20.00K	Grant	—	Jun 27	View
From 4	—	40.00K	—	—	Apr 17, 2014	40.00K	Grant	—	Apr 15	View
From 3	—	—	—	—	Apr 17, 2014	—	—	—	—	View

VNDAvanda pharmaceuticals inc.

Updated: Jun 03, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.09	6.44K	$7.03	-$1.53K	Jun 03, 2022	63.06K	Sale	—	Jun 02	View
From 4	0.30	15.00K	—	—	Jun 14, 2021	64.51K	Grant	—	Jun 10	View
From 4	-0.11	5.82K	$12.83	-$1.21K	Feb 18, 2021	49.51K	Sale	—	Feb 16	View
From 4	0.42	15.00K	—	—	Jun 15, 2020	50.32K	Grant	—	Jun 11	View
From 4	-0.22	9.68K	$9.44	-$585.50	Jun 02, 2020	35.32K	Sale	—	May 29	View
From 4	0.60	15.00K	—	—	Jun 17, 2019	40.00K	Grant	—	Jun 13	View
From 4	0.75	15.00K	—	—	Jun 15, 2018	35.00K	Grant	—	Jun 13	View
From 4	—	30.00K	$4.98	$74.70K	May 04, 2018	20.00K	Options	—	May 03	View
From 4	—	15.00K	—	—	Jun 19, 2017	15.00K	Grant	—	Jun 15	View
From 4	—	15.00K	—	—	Jun 17, 2016	15.00K	Grant	—	Jun 16	View
From 4	—	15.00K	—	—	Jun 22, 2015	15.00K	Grant	—	Jun 18	View
From 4	—	15.00K	—	—	May 27, 2014	15.00K	Grant	—	May 22	View
From 4	-1.00	35.00K	$13.53	-$289.17K	Mar 17, 2014	—	Sale	—	Mar 14	View
From 4	—	15.00K	—	—	Jun 24, 2013	15.00K	Grant	—	Jun 20	View
From 4	—	15.00K	—	—	Jun 18, 2012	15.00K	Grant	—	Jun 14	View
From 4	—	15.00K	—	—	Jun 17, 2011	15.00K	Grant	—	Jun 16	View
From 4	—	15.00K	—	—	Jun 07, 2010	15.00K	Grant	—	Jun 03	View
From 4	—	15.00K	—	—	Aug 31, 2009	15.00K	Grant	—	Aug 27	View
From 4	—	15.00K	—	—	May 12, 2008	15.00K	Grant	—	May 08	View
From 4	—	15.00K	—	—	May 18, 2007	15.00K	Grant	—	May 16	View
From 4	—	35.00K	—	—	Sep 12, 2006	35.00K	Grant	—	Sep 08	View
From 3	—	—	—	—	Sep 12, 2006	—	—	—	—	View

human genome sciences inc

Chief Executive Officer Director

Updated: Aug 17, 2012

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	-1.00	166.08K	$11.96	-$106.69K	Aug 17, 2012	—	Disposition	—	Nov 02 - 30	View
From 4	-1.00	3.50M	$14.25	-$49.89M	Aug 01, 2012	—	Disposition	—	Jul 25 - 30	View
From 4	—	360.00K	—	—	Mar 12, 2012	360.00K	Grant	—	Mar 10	View
From 4	—	400.00K	—	—	Mar 21, 2011	400.00K	Grant	—	Mar 17	View
From 4	10.00	60.00K	$24.16	$1.45M	Jan 07, 2011	232.08K	Purchase	—	Jan 05	View
From 4	0.00	801.28	$19.64	$15.74K	Jul 13, 2010	172.08K	Purchase	—	Jul 12	View
From 4	—	450.00K	—	—	Mar 11, 2010	450.00K	Grant	—	Mar 10	View
From 4	0.01	1.00K	$1.80	$1.80K	Jul 02, 2009	171.27K	Purchase	—	Jun 30	View
From 4	—	500.00K	—	—	Mar 12, 2009	500.00K	Grant	—	Mar 10	View
From 4	1.56	100.00K	$2.02	$202.00K	Nov 14, 2008	170.27K	Purchase	—	Nov 12	View
From 4	0.04	2.28K	$4.49	$10.24K	Jul 02, 2008	70.27K	Purchase	—	Jul 01	View
From 4	0.48	20.00K	$4.93	$98.70K	Mar 12, 2008	67.99K	Purchase	—	Mar 11	View
From 4	—	500.00K	—	—	Mar 11, 2008	500.00K	Grant	—	Mar 10	View
From 4	0.05	1.99K	$7.59	$15.13K	Jul 12, 2007	47.99K	Purchase	—	Jul 11	View
From 4	—	400.00K	—	—	Mar 13, 2007	400.00K	Grant	—	Mar 10	View
From 4	—	6.00K	$12.05	$72.30K	Nov 14, 2006	46.00K	Purchase	—	Nov 10	View
From 4	3.00	30.00K	$11.14	$334.20K	Sep 07, 2006	40.00K	Purchase	—	Sep 05	View
From 4	—	325.00K	—	—	Mar 16, 2006	325.00K	Grant	—	Mar 14	View
From 4	—	10.00K	$11.95	$119.50K	Jan 06, 2005	10.00K	Purchase	—	Jan 05	View
From 4	—	1.25M	—	—	Nov 22, 2004	1.25M	Grant	—	Nov 21	View
From 3	—	—	—	—	Nov 22, 2004	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions